Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04254731

Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals

The Study of Potential Normalization of Cardiac Rhythm Following Drug Exchange From Chimeric Methadone to Active Methadone

Status
Active Not Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Effects of switching from racemic methadone to R-methadone on serum methadone concentrations and QTc intervals

Detailed description

Racemic methadone may prolong the QTc interval, which is associated with fatal arrhythmias. In vitro studies have shown that R-methadone has less inhibitory effect than S-methadone on the voltage-gated potassium channel current, and is thus thought to have less effect on the QTc interval. The investigators hypothesized that switching from racemic to R-methadone would reduce the methadone serum concentration and also its effect on the QTc interval.

Conditions

Interventions

TypeNameDescription
DRUGSame individuals treated with racemic methadone and switched to levomethadone (R-methadone)

Timeline

Start date
2015-05-07
Primary completion
2018-06-27
Completion
2024-07-30
First posted
2020-02-05
Last updated
2024-04-03

Locations

3 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT04254731. Inclusion in this directory is not an endorsement.